Public Profile

Corium, LLC

Corium, LLC, headquartered in the United States, is a leading innovator in the pharmaceutical industry, specialising in advanced drug delivery systems. Founded in 2010, the company has made significant strides in developing unique transdermal and microneedle technologies that enhance patient compliance and therapeutic efficacy. With a focus on transforming the way medications are administered, Corium's core products include its proprietary transdermal patches and microneedle arrays, which stand out for their precision and effectiveness. The company operates primarily in North America, with a growing presence in international markets. Recognised for its commitment to quality and innovation, Corium has achieved notable milestones, including strategic partnerships with major pharmaceutical firms. This positions Corium, LLC as a key player in the evolving landscape of drug delivery solutions, dedicated to improving patient outcomes through cutting-edge technology.

DitchCarbon Score

How does Corium, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Corium, LLC's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

14%

Let us know if this data was useful to you

Corium, LLC's reported carbon emissions

In 2023, Corium, LLC reported a greenhouse gas (GHG) emissions intensity of approximately 2,000 kg CO2e per unit of revenue (tonne) under Scope 1 and 2 emissions. This figure reflects their ongoing commitment to monitoring and managing their carbon footprint. In 2022, the emissions intensity was significantly higher at about 454,850 kg CO2e per tonne of revenue, indicating a substantial reduction in emissions intensity over the year. In 2021, the emissions intensity was recorded at approximately 9,000 kg CO2e per tonne of revenue. Despite these figures, Corium, LLC has not disclosed specific reduction targets or initiatives aimed at further decreasing their carbon emissions. The absence of documented climate pledges or Science-Based Targets Initiative (SBTi) commitments suggests that while they are tracking emissions, they may not yet have formalised strategies for long-term reductions. As the company continues to evolve, further transparency regarding their climate commitments and future reduction strategies will be essential for stakeholders and the broader industry context.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Corium, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Corium, LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Corium, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

DURECT Corporation

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Janssen

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Cumberland Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Zevra Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Supernus Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Ironshore Pharmaceuticals Inc.

KY
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers